Our client, a thriving Chinese fund with a DPI (Distribution to Paid-In Capital) ratio exceeding 10, focuses on investments in the biopharmaceutical sector. This field demands investors to possess scientific expertise in drug development and disease treatment while keeping an eye on groundbreaking scientific advancements.
Traditionally, investors in the biopharmaceutical sector rely on academic papers from top international journals for the latest insights. Similarly, our client had a team of Ph.D. interns who manually reviewed journals like "Nature" and "Science," sifting through numerous papers and compiling briefs for the investment team every week.
However, this approach had limitations:
To tackle these challenges, we introduced SourceWire. It not only efficiently tracks critical sources but also employs customized algorithms to tag research papers, replicating an investor's judgment. We created an algorithm based on our client's input of 1,300 tagged papers to automatically filter thousands of papers, ensuring that only the most promising and valuable research reaches the investment team.
Now, the team efficiently keeps tabs on cutting-edge information, liberating time and resources for more impactful work.
Some teams encounter two challenges in information collection:
SourceWire can tailor algorithms for clients, achieving consistent information selection.
Beijing SourceEngine Technology, LLC.
Copyright © 2023 Beijing SourceEngine Technology, LLC. All Rights Reserved.